Antigen-binding polypeptides against cartilage degeneration

Details for Australian Patent Application No. 2009212079 (hide)

Owner Delenex Therapeutics AG

Inventors Urech, David; Lichtlen, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2009212079

PCT Pub. Number WO2009/097704

Priority 61/026,317 05.02.08 US; 61/088,876 14.08.08 US

Filing date 5 February 2009

Wipo publication date 13 August 2009

Acceptance publication date 30 August 2012

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/00 Drugs for skeletal disorders

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

29 July 2010 PCT application entered the National Phase

  PCT publication WO2009/097704 Priority application(s): WO2009/097704

30 August 2012 Application Accepted

  Published as AU-B-2009212079

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212083-Injection syringe

2009212077-Mouthpiece and process for production